Novo Nordisk
NVO
#14
Rank
$572.92 B
Marketcap
$128.40
Share price
0.27%
Change (1 day)
65.34%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2023 (TTM): $15.42 B

According to Novo Nordisk's latest financial reports the company's current earnings (TTM) are $15.42 B. an increase over its 2022 earnings that were of $9.78 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 2001 to 2023

Annual earnings

Year Earnings Change
2023$15.42 B57.64%
2022$9.78 B5.35%
2021$9.29 B12.47%
2020$8.26 B13.07%
2019$7.30 B-3.35%
2018$7.55 B1.79%
2017$7.42 B4.52%
2016$7.10 B9.42%
2015$6.49 B8.24%
2014$5.99 B3.45%
2013$5.79 B19.02%
2012$4.87 B15.21%
2011$4.22 B17.71%
2010$3.59 B24.78%
2009$2.87 B10.62%
2008$2.60 B55.97%
2007$1.66 B7.07%
2006$1.55 B18.18%
2005$1.31 B11.33%
2004$1.18 B
2002$0.76 B-14.39%
2001$0.89 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$3.26 B-78.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.55 B-57.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.39 B-45.59%๐Ÿ‡ซ๐Ÿ‡ท France
$8.44 B-45.30%๐Ÿ‡บ๐Ÿ‡ธ USA